FR14C0044I2 - Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes - Google Patents

Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes

Info

Publication number
FR14C0044I2
FR14C0044I2 FR14C0044C FR14C0044C FR14C0044I2 FR 14C0044 I2 FR14C0044 I2 FR 14C0044I2 FR 14C0044 C FR14C0044 C FR 14C0044C FR 14C0044 C FR14C0044 C FR 14C0044C FR 14C0044 I2 FR14C0044 I2 FR 14C0044I2
Authority
FR
France
Prior art keywords
cephemes
bipyrrolidinyl
ylidenemethyl
oxo
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR14C0044C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of FR14C0044I1 publication Critical patent/FR14C0044I1/fr
Application granted granted Critical
Publication of FR14C0044I2 publication Critical patent/FR14C0044I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR14C0044C 1998-06-15 2014-06-11 Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes Active FR14C0044I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98110888 1998-06-15
EP98117099 1998-09-10
PCT/EP1999/003907 WO1999065920A1 (en) 1998-06-15 1999-06-07 Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
EP99927894A EP1087980B1 (en) 1998-06-15 1999-06-07 Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems

Publications (2)

Publication Number Publication Date
FR14C0044I1 FR14C0044I1 (es) 2014-07-18
FR14C0044I2 true FR14C0044I2 (fr) 2015-02-20

Family

ID=26149347

Family Applications (1)

Application Number Title Priority Date Filing Date
FR14C0044C Active FR14C0044I2 (fr) 1998-06-15 2014-06-11 Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes

Country Status (28)

Country Link
EP (1) EP1087980B1 (es)
JP (1) JP3872955B2 (es)
KR (1) KR100411915B1 (es)
CN (1) CN1136222C (es)
AR (1) AR018675A1 (es)
AT (1) ATE231871T1 (es)
AU (1) AU754732B2 (es)
BE (1) BE2014C034I2 (es)
BR (2) BRPI9911178C1 (es)
CA (1) CA2334568C (es)
CO (1) CO5080758A1 (es)
DE (1) DE69905162T2 (es)
DK (1) DK1087980T3 (es)
ES (1) ES2190222T3 (es)
FR (1) FR14C0044I2 (es)
GT (1) GT199900084A (es)
HU (1) HUP0105426A3 (es)
ID (1) ID27686A (es)
IL (1) IL139872A0 (es)
LU (1) LU92564I2 (es)
MA (1) MA26650A1 (es)
NO (1) NO20006350L (es)
PA (1) PA8475701A1 (es)
PE (1) PE20000645A1 (es)
PL (1) PL344994A1 (es)
SV (1) SV1999000075A (es)
TN (1) TNSN99114A1 (es)
WO (1) WO1999065920A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6267100A (en) * 1999-07-07 2001-01-30 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
ES2272372T3 (es) 2000-04-19 2007-05-01 Basilea Pharmaceutica Ag Procedimiento para la preparacion de derivados de asparagina.
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
MXPA05010083A (es) * 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
KR20120016662A (ko) * 2009-05-25 2012-02-24 산도즈 아게 세프토비프롤 메도카릴의 제조 방법
WO2011141415A1 (en) 2010-05-10 2011-11-17 Basilea Pharmaceutica International Ltd. Oxidation process for preparing 3-formyl-cephem derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0841339T3 (da) * 1996-11-06 2007-07-02 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporinderivater
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents

Also Published As

Publication number Publication date
PE20000645A1 (es) 2000-07-26
KR20010052866A (ko) 2001-06-25
WO1999065920A1 (en) 1999-12-23
BE2014C034I2 (en) 2018-08-24
AU4508199A (en) 2000-01-05
AU754732B2 (en) 2002-11-21
IL139872A0 (en) 2002-02-10
PL344994A1 (en) 2001-11-19
ES2190222T3 (es) 2003-07-16
BR9911178A (pt) 2001-03-13
NO20006350D0 (no) 2000-12-13
EP1087980A1 (en) 2001-04-04
TNSN99114A1 (fr) 2005-11-10
CA2334568A1 (en) 1999-12-23
BR9911178B1 (pt) 2013-10-29
NO20006350L (no) 2000-12-13
MA26650A1 (fr) 2004-12-20
DE69905162T2 (de) 2003-12-24
HUP0105426A3 (en) 2002-12-28
PA8475701A1 (es) 2000-09-29
LU92564I2 (fr) 2014-12-01
ATE231871T1 (de) 2003-02-15
CN1136222C (zh) 2004-01-28
CA2334568C (en) 2009-02-24
AR018675A1 (es) 2001-11-28
JP3872955B2 (ja) 2007-01-24
DE69905162D1 (de) 2003-03-06
JP2002518401A (ja) 2002-06-25
KR100411915B1 (ko) 2003-12-18
ID27686A (id) 2001-04-19
GT199900084A (es) 2000-12-05
EP1087980B1 (en) 2003-01-29
BRPI9911178B8 (pt) 2017-03-07
HUP0105426A2 (hu) 2002-05-29
CN1305484A (zh) 2001-07-25
FR14C0044I1 (es) 2014-07-18
CO5080758A1 (es) 2001-09-25
BRPI9911178C1 (pt) 2021-05-25
SV1999000075A (es) 2000-05-02
DK1087980T3 (da) 2003-05-26

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
FR14C0044I2 (fr) Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes
DE69907964D1 (de) 1,2-annelierte chinolinderivate
MA26831A1 (fr) Derives de benzodiazepine."
MA26816A1 (fr) Derives d'amino-triazolopyridine
DE69716468T2 (de) 2-(purin-9-)-tetrahydrofuran-3,4-diol-derivate
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
PT1060183E (pt) Derivados de 5'-desoxicitidina
PT1129079E (pt) Derivados de triazina 2,4-dissubstituidos
ATE243218T1 (de) 2''-deoxyhygromycinderivate
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
NO20015397L (no) 1,5-Benzodiazepin-derivater
ES1041880Y (es) Puya de picador.
FI980405A0 (fi) Industriellt, kontinuerligt foerfarande foer framstaellning av "gravkalk"
BR1100649A (pt) Derivados de 10,11-metano dibenzo suberano
MA26495A1 (fr) Derives d'exomethylene